Wall Street Teacher (a pseudonym) worked on Wall Street for several years in the fixed income area and now teaches and writes on financial topics (primarily regulation and markets). Current interests include the psychology of financial markets, the origins of chemistry/physics, synthetic biology, human evolution,siege engines, antique prints, truffles, old cameras, debunking "short and distort" hit pieces, picking RJ Kirk's brain, Battlefield III (we all have our vices) and horology.
I'm a value investor focused on buying companies trading below the intrinsic value.
I've a back ground in engineering & finance. I'm also a Chartered Financial Analyst. I did my MBA from Emory University's Goizueta School of Business
Chris is the founder of a new Austin-based startup in the beta testing phase.
He is entrepreneur with significant experience researching and evaluating a broad spectrum of subjects, including: technology, investments and private equity opportunities.
Previously he served as Director of Marketing & Technology at Axion Capital Management / Axion Opportunity Fund. A top ranked boutique absolute return fund with a global perspective.
Graycell Advisors publishes stock portfolios using quantitative-driven models and systematic investing. For 2016, Graycell Smallcap Portfolio was up +71% compared to benchmark Russell 2000 Index gain of +9%.
All Seeking Alpha articles under Graycell Advisors are written by Tarun Chandra, who has prior experience as an Equity Analyst on the Sellside and Buyside, as well as experience in Corporate Strategy and Finance. More Seeking Alpha articles can be viewed under the 2nd ID, Tarun Chandra, CFA, where we publish mostly on Biotech. In addition, we have a Graycell Blog and a Prudent Biotech Blog for more updated coverage.
We invite you to take a look at the Performance, Samples, and Philosophy, and decide for yourself if the Small Cap and Biotech products can contribute to your investment objectives. You can even view Samples, Register for a Free Pick from the Portfolio, and check the risk-free subscription with a 2-month money back guarantee.
Nothing here or on the site constitutes a personalized investment recommendation, and stocks mentioned in the reports/articles/comments may be now or in the past, part of the portfolios recommended by Graycell Advisors and related entities. Graycell Advisors and related entities are not a Registered Investment Advisor (RIA).
Any questions, please write to Support @ GraycellAdvisors.com
I am a medical professional that enjoys investing in biotech stocks. I take long positions and may dabble in options. I have a particular interest in biotechs with an ophthalmic (eye) focus as that is where I have developed the greatest expertise over my career and research. I hope over time to share some of my professional insights with those of the Seeking Alpha community in order to help them make more informed investing decisions. I expect to learn a lot from others as well.
I am long the following biotechs at this time: GILD, OPHT, CRMD, ACAD, RLYP, HALO, TGTX, APHB, ZIOP.
I am advising everyone to avoid: OHRP